✓ Last verified: March 25, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: North Side location of Loop Medical Center offering IV and intranasal ketamine in the Streeterville neighborhood near the Magnificent Mile
| Google Reviews | Reviewed on Yelp |
| Location | Streeterville, Chicago, Illinois |
| Address | 432 E Grand Ave, Suite A, Chicago, IL 60611 |
| Phone | (312) 414-1088 |
| Website | loopmedicalcenter.com |
| Treatments | IV Ketamine Infusion, Intranasal Ketamine, Pain Management, Regenerative Medicine |
| Conditions | Depression, Bipolar Disorder, Anxiety, PTSD, OCD, Fibromyalgia, Addiction, Chronic Pain |
| Cost | Contact clinic for pricing |
| Insurance | Contact clinic |
| KAP Available | Contact clinic |
| Clinical Lead | Contact clinic |
HealingMaps Take: The Streeterville location of Loop Medical Center brings the same comprehensive ketamine therapy options to Chicago’s North Side. Located on Grand Avenue near the Magnificent Mile, this location offers earlier morning hours (8am-4pm) compared to the South Loop office, which may suit patients with afternoon commitments. The same IV and intranasal ketamine protocols are available here for both mood disorders and chronic pain conditions.
Market Position: Loop Medical Center is a Spravato-certified clinic in the Chicago metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. Loop Medical Center has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 6-question summary is matched to the protocols and conditions Loop Medical Center treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Loop Medical Center offers Spravato and IV ketamine — a 2-protocol practice. Patients can switch between or combine modalities without changing providers. Confirm specific dosing schedules and which protocols are recommended for your condition during your consult.
Yes — Loop Medical Center offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Loop Medical Center treats depression via Spravato (FDA-approved for TRD), and IV ketamine (off-label, evidence-based). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Loop Medical Center treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — Loop Medical Center treats PTSD. Both Spravato and IV ketamine can be used for trauma. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Loop Medical Center treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply